These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19412915)
1. Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy. Akolekar R; Minekawa R; Veduta A; Romero XC; Nicolaides KH Prenat Diagn; 2009 Aug; 29(8):753-60. PubMed ID: 19412915 [TBL] [Abstract][Full Text] [Related]
2. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425 [TBL] [Abstract][Full Text] [Related]
3. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Yu J; Shixia CZ; Wu Y; Duan T Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451 [TBL] [Abstract][Full Text] [Related]
4. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler. Aquilina J; Thompson O; Thilaganathan B; Harrington K Ultrasound Obstet Gynecol; 2001 Jun; 17(6):477-84. PubMed ID: 11422967 [TBL] [Abstract][Full Text] [Related]
5. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation. Spencer K; Yu CK; Savvidou M; Papageorghiou AT; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Jun; 27(6):658-63. PubMed ID: 16493628 [TBL] [Abstract][Full Text] [Related]
6. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Poon LC; Stratieva V; Piras S; Piri S; Nicolaides KH Prenat Diagn; 2010 Mar; 30(3):216-23. PubMed ID: 20108221 [TBL] [Abstract][Full Text] [Related]
7. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Plasencia W; Maiz N; Poon L; Yu C; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Aug; 32(2):138-46. PubMed ID: 18634131 [TBL] [Abstract][Full Text] [Related]
9. First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsia and chromosomal defects. Staboulidou I; Galindo A; Maiz N; Karagiannis G; Nicolaides KH Fetal Diagn Ther; 2009; 25(3):336-9. PubMed ID: 19776597 [TBL] [Abstract][Full Text] [Related]
10. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Poon LC; Akolekar R; Lachmann R; Beta J; Nicolaides KH Ultrasound Obstet Gynecol; 2010 Jun; 35(6):662-70. PubMed ID: 20232288 [TBL] [Abstract][Full Text] [Related]
11. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788 [TBL] [Abstract][Full Text] [Related]
12. First-trimester prediction of hypertensive disorders in pregnancy. Poon LC; Kametas NA; Maiz N; Akolekar R; Nicolaides KH Hypertension; 2009 May; 53(5):812-8. PubMed ID: 19273739 [TBL] [Abstract][Full Text] [Related]
13. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Florio P; Reis FM; Pezzani I; Luisi S; Severi FM; Petraglia F Ultrasound Obstet Gynecol; 2003 Feb; 21(2):165-9. PubMed ID: 12601840 [TBL] [Abstract][Full Text] [Related]
14. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia. Spencer K; Cowans NJ; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493 [TBL] [Abstract][Full Text] [Related]
15. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Onwudiwe N; Yu CK; Poon LC; Spiliopoulos I; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Dec; 32(7):877-83. PubMed ID: 18991324 [TBL] [Abstract][Full Text] [Related]
16. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women. Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443 [TBL] [Abstract][Full Text] [Related]
18. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293 [TBL] [Abstract][Full Text] [Related]